BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mudie DM, Stewart AM, Rosales JA, Biswas N, Adam MS, Smith A, Craig CD, Morgen MM, Vodak DT. Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs. Pharmaceutics 2021;13:557. [PMID: 33921109 DOI: 10.3390/pharmaceutics13040557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Butreddy A. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic. Eur J Pharm Biopharm 2022:S0939-6411(22)00148-5. [PMID: 35872180 DOI: 10.1016/j.ejpb.2022.07.010] [Reference Citation Analysis]
2 Qi Q, Taylor LS. Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation. Int J Pharm 2022;622:121886. [PMID: 35661745 DOI: 10.1016/j.ijpharm.2022.121886] [Reference Citation Analysis]
3 Mudie DM, Stewart AM, Rosales JA, Adam MS, Morgen MM, Vodak DT. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021;13:1257. [PMID: 34452217 DOI: 10.3390/pharmaceutics13081257] [Cited by in F6Publishing: 3] [Reference Citation Analysis]